0000899243-22-029561.txt : 20220823 0000899243-22-029561.hdr.sgml : 20220823 20220823194317 ACCESSION NUMBER: 0000899243-22-029561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220822 FILED AS OF DATE: 20220823 DATE AS OF CHANGE: 20220823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ildstad Suzanne CENTRAL INDEX KEY: 0001845822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 221188615 MAIL ADDRESS: STREET 1: C/O TALARIS THERAPEUTICS, INC. STREET 2: 93 WORCESTER STREET, SUITE 120 CITY: WELLESLEY STATE: MA ZIP: 02481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Talaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 570 PRESTON ST. STREET 2: SUITE 400 CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 502-398-9250 MAIL ADDRESS: STREET 1: 93 WORCESTER STREET CITY: WELLESLEY STATE: MA ZIP: 02481 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-22 0 0001827506 Talaris Therapeutics, Inc. TALS 0001845822 Ildstad Suzanne C/O TALARIS THERAPEUTICS, INC. 570 S. PRESTON STREET LOUISVILLE KY 40202 0 1 0 0 Chief Scientific Officer Common Stock 2022-08-22 4 S 0 525000 2.80 D 3081446 D Common Stock 1200000 I By GRAT Common Stock 654205 I See Footnote Common Stock 654205 I See Footnote These shares are held in a trust for the benefit of the Reporting Person's son. The Reporting Person's son is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's daughter is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. /s/ Mary Kay Fenton, attorney-in-fact 2022-08-23